Home
About
Overview
Sharing Data
ORCID
Help
History (31)
Electronic cigarette and combustible cigarette use following a campus-wide ban: Prevalence of use and harm perceptions.
Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes.
Using AHRQ patient safety indicators to detect postdischarge adverse events in the Veterans Health Administration.
Food-Grade Titanium Dioxide Particles Decreased the Bioaccessibility of Vitamin D3 in the Simulated Human Gastrointestinal Tract.
TAD disruption as oncogenic driver.
See All 31 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TAD disruption as oncogenic driver.
Valton AL, Dekker J. TAD disruption as oncogenic driver. Curr Opin Genet Dev. 2016 02; 36:34-40.
View in:
PubMed
subject areas
Carcinogenesis
Chromatin
Gene Expression Regulation, Neoplastic
Genome, Human
Genomics
Humans
Oncogene Proteins, Fusion
Protein Domains
authors with profiles
Job Dekker PhD